LAB11 THERAPEUTICS INC.

Brooklyn, NY · Biotech · Private

Modified mRNA (modRNA) therapeutic cocktails that enhance interferon response to suppress viral replication in influenza A and SARS-CoV-2 infections.

lab11therapeutics.org →
Grants
$512K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Transient Gene Therapy as Broad Spectrum Antiviral$255,932
Federal grantDepartment of Health and Human Services · Phase I · Transient Gene Therapy as Broad Spectrum Antiviral$255,932
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2687ARTIAM BIO INC.——
2688RegenX LLC——
2689THINK BIOSCIENCE, INC.——
2690LAB11 THERAPEUTICS INC.——
2691SD NANOSCIENCES, INC.——
2692OOMNI, INC.——
2693STEMMED, LTD——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.